Effects of combined sex hormone replacement therapy on small artery biomechanics in pharmacologically ovariectomized rats

Maturitas

Volumn 34, Issue 1, 2000, Pages 83-92

  Acs, Nandor ^a   Székács, B éla ^a   Nádasy, György L ^a   Várbíró, Szabolcs ^a   Miklós, Zsuzsanna ^a   Szentiványi Jr, M átyás ^a   Monos, Emil ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Hormone replacement therapy; Medroxyprogesterone; Rat; Resistance vessel and vascular biomechanics; Small artery

Indexed keywords

ESTRADIOL PROPIONATE; MEDROXYPROGESTERONE ACETATE; NORADRENALIN; PAPAVERINE; TRIPTORELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY; ARTERY COMPLIANCE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTERY WALL; ARTICLE; BIOMECHANICS; BLOOD VESSEL REACTIVITY; CASTRATION; CONTROLLED STUDY; ELASTICITY; FEMALE; HORMONE SUBSTITUTION; MORPHOLOGY; NONHUMAN; OVARIECTOMY; RAT; RESISTANCE BLOOD VESSEL;

ANIMALS; ARTERIES; BIOMECHANICS; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; LUTEOLYTIC AGENTS; MEDROXYPROGESTERONE 17-ACETATE; OVARIECTOMY; POSTMENOPAUSE; RATS; RATS, SPRAGUE-DAWLEY; TRIPTORELIN; VASCULAR RESISTANCE;

ANIMALIA;

EID: 0034650374     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00086-9     Document Type: Article

References (33)

1. Grodstein F., Stampfer M.J., Manson J.A. et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New Engl. J. Med. 335:1996;453-461.
2. Hulley S., Grady D., Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J. Am. Med. Assoc. 280:1998;605-613.
3. Nabulsi A.A., Folsom A.R., White A. et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. New Engl. J. Med. 328:1993;1069-1075.
4. Gerhard M., Ganz P. How do we explain the clinical benefits of estrogen? Circulation. 92:1995;5-8.
5. Lobo R.A. The role of progestins in hormone replacement therapy. Am. J. Obstet. Gynecol. 166:1992;1997-2004.
6. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J. Am. Med. Assoc. 273:1995;199-208.
7. Sarrel P.M. Blood flow. Lobo R.A. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. 1994;251-262 Raven Press, New York.
8. Jiang C., Sarrel P.M., Poole-Wilson P.A., Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am. J. Physiol. 263:1992;H271-275.
9. Kakucs R., Székács B., Nádasy G.L., Acs N., Monos E. Direct relaxing effect of estradiol-17 beta and progesterone on rat saphenous artery. Microvasc. Res. 56:1998;139-143.
10. Acs N., Székács B., Nádasy G.L. et al. The effect of ovariectomy and oestrogen replacement on small artery biomechanics in the rat. Br. J. Obstet. Gynecol. 106:1999;148-154.
11. Okada H., Doken Y., Ogawa Y. Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate. J. Pharm. Sci. 85:1996;1044-1048.
12. Sturm G., Haberlein H., Bauer T., Plaum T., Stalker D.J. Mass spectrometric and high performance liquid chromatographic studies of medroxyprogesterone acetate metabolites in human plasma. J. Chromatogr. 562:1991;351-362.
13. Monos E., Contney S.J., Dornyei G., Cowley A.W. Jr, Stekiel W.J. Hyperpolarization of in situ rat saphenous vein in response to axial stretch. Am. J. Physiol. 265:1993;H857-H861.
14. Monos E., Kovách A.G.B. Biomechanical properties of splenic artery. Acta. Physiol. Hung. 55:1980;355-364.
15. Cox R.H. Three-dimensional mechanics of arterial segments in vitro: methods. J. Appl. Physiol. 36:1974;381-384.
16. Levine R.L., Chen S.J., Durand J., Chen Y.F., Oparil S. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation. 94:1996;2221-2227.
17. Adams M.R., Register T.C., Golden D.L., Wagner J.D., Williams J.K. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:1997;217-221.
18. Jiang C., Sarrel P.M., Lindsay D.C. et al. 17-Beta estradiol has calcium antagonistic properties in the rabbit coronary artery in vitro. Circulation. 84(Suppl II):1991;272.
19. Veille J.C., Li P., Eisenach J.C. et al. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine arteries and renal arteries in vitro. Am. J. Obstet. Gynecol. 174:1996;1043-1049.
20. Williams J.K., Honore E.K., Washburn S.A., Clarkson T.B. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J. Am. Coll. Cardiol. 27:1994;1757-1761.
21. Miyagawa K., Rosch J., Stanczyk F., Hermsmeyer K. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat. Med. 3:1997;324-327.
22. Miller V.M., Vanhoutte P.M. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am. J. Physiol. 261:1991;R1022-R1027.
23. Kuhl H. Effects of progestogens on hemostasis. Maturitas. 24:1996;1-19.
24. Belfort M.A., Saade G.R., Suresh M., Vedernikov Y.P. Effects of estradiol-17 beta and progesterone on isolated human omental artery from premenopausal nonpregnant women and from normotensive and preeclamptic pregnant women. Am. J. Obstet. Gynecol. 174:1996;246-253.
25. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Progesterone induces endotheluim-independent relaxation of rabbit coronary artery in vitro. Eur. J. Pharmacol. 211:1992;163-167.
26. Perusquia M., Hernandez M., Morales M.A., Campos M.G., Villalon C.M. Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta. Gen. Pharmacol. 27:1996;181-185.
27. Morey A.K., Pedram A., Razandi M., Prins B.A., Hu R.M., Biesiada E., Levin E.R. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology. 138:1997;3330-3339.
28. Tollan A., Oian P., Kjeldsen S.E., Eide I., Maltau J.M. Progesterone reduces sympathetic tone without changing blood pressure or fluid balance in men. Gynecol. Obstet. Invest. 36:1993;234-238.
29. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic arteries of premenopausal women. Circulation. 89:1994;1501-1510.
30. Perrot-Applanat M., Cohen-Solal K., Milgrom E., Finet M. Progesterone receptor expression in human saphenous veins. Circulation. 92:1995;2975-2983.
31. Kim-Schultze S., McGowan K.A., Hubchak S.C., Cid M.C., Martin M.B., Kleinman H.K., Greene G.L., Schnaper H.W. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 94:1996;1402-1407.
32. Hegele-Hartung C., Fritzmeyer K.H., Diel P. Effects of a pure antiestrogen and progesterone on estrogen-mediated alterations of blood flow and progesterone receptor expression in the aorta of ovariectomized rabbits. J. Steroid. Biochem. Mol. Biol. 63:1997;237-249.
33. Huang A., Sun D., Kaley G., Koller A. Estrogen preserves regulation of shear stress by nitric oxide in arteriole of female hypertensive rats. Hypertension. 31:1998;309-314.